D016898Chemicals & DrugsD12.644.276.374.440.890.250D12.776.467.374.440.890.250D23.529.374.440.890.250832330.923677Interferon-alphaprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMichaelCharltonMichael Charlton0.000000000000000.000000000000003423Charlton, MichaelProfessorMedicine-Gastroenterology29305625Coomans de Brachène A, Dos Santos RS, Marroqui L, Colli ML, Marselli L, Mirmira RG, Marchetti P, Eizirik DLDiabetologiaIFN-a induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells. Diabetologia. 2018 03; 61(3):636-640.Diabetologia2018-01-05T00:00:002018IFN-a induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells.31042581Chen H, Sun J, Zhou B, Xie Q, Liang X, Fan R, Conran C, Xu J, Ji Y, Zhang X, Sun L, Jia J, Wang G, Hou J, Jiang DKClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationVariants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha. Clin Gastroenterol Hepatol. 2020 01; 18(1):196-204.e8.Clin Gastroenterol Hepatol2019-04-28T00:00:002019Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha.Medicine-Hematology and Oncology1.394840.0061792383research area of0.7111780.0221128196subject area forMedicineUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.ProfessorWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.ProfessorHarvey M.GolombHarvey M. Golomb41.78927490000000-87.601250000000002105Golomb, Harvey M.ProfessorYusukeNakamuraYusuke Nakamura41.78927490000000-87.60125000000000582Nakamura, YusukeEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor25338677Kariuki SN, Ghodke-Puranik Y, Dorschner JM, Chrabot BS, Kelly JA, Tsao BP, Kimberly RP, Alarcón-Riquelme ME, Jacob CO, Criswell LA, Sivils KL, Langefeld CD, Harley JB, Skol AD, Niewold TBGenes and immunityGenetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus. Genes Immun. 2015 Jan-Feb; 16(1):15-23.Genes Immun2014-10-23T00:00:002014Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.25677867Halabi S, Rini BI, Escudier B, Stadler WM, Small EJCancerProgression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint? Cancer. 2015 Jun 01; 121(11):1906.Cancer2015-02-11T00:00:002015Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?26382862Chiang JJ, Gack MUNature immunologyReading the fine print: sequence-specific activation of cGAS. Nat Immunol. 2015 Oct; 16(10):1009-10.Nat Immunol2015-10-01T00:00:002015Reading the fine print: sequence-specific activation of cGAS.